Medicare Enrolled
Dr. Ilan Safir, M.D.
Urology Physician · Manhasset, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Safir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Safir?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Safir
Dr. Ilan Safir is an urology physician in Manhasset, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Safir performed 54,842 Medicare services across 6,122 unique beneficiaries.
Between the years covered by Open Payments, Dr. Safir received a total of $14,578 from 61 pharmaceutical and/or device companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Safir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 1% volume in NY
$14,578 industry payments
Medicare Practice Summary
Medicare Utilization ↗54,842
Medicare services
Top 1% in NY for urology physician
6,122
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,917 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
39,200 | $0 | $0 |
| BCG treatment for bladder cancer | 4,600 | $2 | $9 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,532 | $2 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,442 | $115 | $441 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
1,015 | $113 | $422 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
1,014 | $8 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
749 | $8 | $9 |
| Leuprolide injectable, camcevi, 1 mg | 630 | $66 | $287 |
| PSA test (prostate cancer screening) | 612 | $18 | $55 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
559 | $80 | $313 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
512 | $8 | $26 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
364 | $47 | $172 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
299 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
299 | $8 | $24 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
281 | $11 | $48 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
195 | $57 | $220 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
174 | $152 | $579 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
157 | $228 | $966 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
153 | $12 | $49 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
132 | $50 | $203 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
121 | $80 | $290 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
110 | $84 | $426 |
| Antimicrobial drug detection test A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample. |
67 | $5 | $14 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
63 | $103 | $394 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
61 | $25 | $77 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
61 | $122 | $446 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
55 | $22 | $273 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
48 | $32 | $121 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
46 | $10 | $32 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
40 | $127 | $1,443 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
27 | $67 | $594 |
| Bladder and urethra clot removal with endoscope A procedure using an endoscope to irrigate and remove multiple blood clots from the bladder and urethra. |
22 | $272 | $1,562 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
21 | $28 | $227 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
21 | $126 | $1,087 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
21 | $313 | $1,330 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
19 | $8 | $25 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
17 | $393 | $1,435 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
16 | $286 | $1,305 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
15 | $105 | $2,699 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
13 | $7 | $167 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
13 | $112 | $1,357 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
12 | $138 | $691 |
| Emergency department visit, straightforward decision making An emergency department visit for a patient with a straightforward medical decision making process. |
12 | $40 | $146 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
11 | $205 | $851 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
11 | $133 | $495 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
72.5% medium
27.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,578
Total received (2018-2024)
Avg $2,083/year across 7 years
Top 15% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
437
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,893 (61.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,352 (29.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,333 (9.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,672
2023
$5,181
2022
$3,156
2021
$1,667
2020
$871
2019
$1,488
2018
$545
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$521
Astellas Pharma US Inc
$223
Janssen Biotech, Inc.
$173
ABBVIE INC.
$170
180 Medical, Inc.
$68
Galvanize Therapeutics, Inc
$66
UROGEN PHARMA, INC.
$61
Telix Pharmaceuticals
$45
BLUEWIND MEDICAL
$43
Antares Pharma, Inc.
$39
ABC Home Medical Supply, Inc.
$35
Dendreon Pharmaceuticals LLC
$31
COLOPLAST CORP
$25
Merck Sharp & Dohme LLC
$22
PROGENICS PHARMACEUTICALS, INC.
$22
Verity Pharmaceuticals Inc.
$22
Teleflex LLC
$21
Tolmar, Inc.
$20
PFIZER INC.
$19
ACCORD HEALTHCARE, INC.
$17
Bayer Healthcare Pharmaceuticals Inc.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Top 3 companies account for 54.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,491
Astellas Pharma US Inc
$1,587
Janssen Scientific Affairs, LLC
$1,104
Bayer HealthCare Pharmaceuticals Inc.
$1,074
Bayer Healthcare Pharmaceuticals Inc.
$1,071
Sumitomo Pharma America, Inc.
$866
NeoTract Inc.
$573
Teleflex LLC
$434
Dendreon Pharmaceuticals LLC
$416
180 Medical, Inc.
$335
PFIZER INC.
$330
Antares Pharma, Inc.
$290
UROVANT SCIENCES INC
$251
ABBVIE INC.
$250
C. R. Bard, Inc. & Subsidiaries
$250
Endo Pharmaceuticals Inc.
$233
Myovant Sciences Inc.
$222
Coloplast Corp
$174
PROCEPT BioRobotics Corporation
$167
AbbVie Inc.
$163
Boston Scientific Corporation
$159
Hollister Incorporated
$156
Aytu BioScience, Inc
$152
AstraZeneca Pharmaceuticals LP
$148
Ferring Pharmaceuticals Inc.
$144
TOLMAR Pharmaceuticals, Inc.
$124
Acerus Pharmaceuticals Corporation
$120
Allergan, Inc.
$117
Merck Sharp & Dohme LLC
$100
Amgen Inc.
$100
ABC Home Medical Supply, Inc.
$91
Galvanize Therapeutics, Inc
$66
UROGEN PHARMA, INC.
$61
ACCORD HEALTHCARE, INC.
$56
Verity Pharmaceuticals Inc.
$52
COLOPLAST CORP
$45
Telix Pharmaceuticals
$45
BLUEWIND MEDICAL
$43
Blue Earth Diagnostics Limited
$40
UroGen Pharma, Inc.
$38
Kowa Pharmaceuticals America, Inc.
$32
Mission Pharmacal Company
$31
Aytu Bioscience, Inc
$30
EMD Serono, Inc.
$30
Supernus Pharmaceuticals, Inc.
$29
Progenics Pharmaceuticals, Inc.
$29
Laborie Medical Technologies Corp.
$26
PROGENICS PHARMACEUTICALS, INC.
$22
Myriad Genetic Laboratories, Inc.
$21
Tolmar, Inc.
$20
Accord Healthcare, Inc.
$19
Clarus Therapeutics Inc.
$19
Olympus America Inc.
$18
MEDIVATION FIELD SOLUTIONS LLC
$17
Zyla Life Sciences
$17
DENTSPLY IH Inc.
$14
Travere Therapeutics, Inc.
$14
Avadel Specialty Pharmaceuticals, LLC
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Sun Pharmaceutical Industries Inc.
$12
Retrophin, Inc.
$12
Top 3 companies account for 35.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ALIYA SYSTEM · AQUABEAM ROBOTIC SYSTEM · AVEED · Axumin · BOTOX · Bavencio · CAMCEVI · ELIGARD · ERLEADA · Erleada · FENSOLVI · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL MALE SUI · GENERAL - BPH · GENERAL - KIDNEY STONE DISEASE · ILLUCCIX · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · LoFric · Luja Coude · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · PREMARIN · PROVENGE · PYLARIFY · Prolaris · Prolia · REVI · SEGLENTIS · SPEEDICATH · SPRIX · SpeediCath · Thiola · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · VAPRO · VESICARE · VaPro · VaPro Pocket · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
677
Per 100K population
48.8
County median income
$143,408
Nearest hospital
NORTH SHORE UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Safir is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with low-engagement industry engagement in the top 15% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Safir experienced with testosterone injection?
Based on Medicare claims data, Dr. Safir performed 39,200 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Safir receive payments from pharmaceutical companies?
Yes. Dr. Safir received a total of $14,578 from 61 companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Safir's costs compare to other urology physicians in Manhasset?
Dr. Safir's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Safir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Manhasset
Browse urology physicians in Manhasset ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology